REG - Wells Fargo & Co - Doc re. Schedule 14A

Wells Fargo & CoAnnouncement

15/03/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220315:nRSO7505Ea&default-theme=true

RNS Number : 7505E  Wells Fargo & Company  14 March 2022

Publication of Definitive Proxy Statement for Wells Fargo & Company

On 14 March 2022, Wells Fargo & Company filed with the U.S. Securities and
Exchange Commission its definitive Proxy Statement for its 2022 Annual Meeting
of Stockholders.

Copies of this document can be downloaded via the following link:

http://www.rns-pdf.londonstockexchange.com/rns/7505E_1-2022-3-14.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/7505E_1-2022-3-14.pdf)

 

For further information, please contact:

 

Media:

Beth Richek

+1 980-308-1568

 

Investors:

John M. Campbell

+1 415-396-0523

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DOCDBGDXLUBDGDS